Pharmacogenotyping of CYP3A5 in predicting dose-adjusted trough levels of tacrolimus among Malaysian kidney-transplant patients

by Hamzah S.; Teh L.K.; Siew J.S.K.; Ahmad G.; Wong H.S.; Zakaria Z.A.; Salleh M.Z.
Published in Canadian Journal of Physiology and Pharmacology (2014)

The impact of COVID-19 pandemic on psychological wellbeing of oncology healthcare providers in Malaysia

by Zainal, N.; Ishak, W. Wan; Ng, C.; Roslani, A.; Gan, G.; Wong, W.; Isa, M.; Pathy, N. Bhoo; Woo, Y.; Abu Bakar, M.; Mohamaed, R.; Rahman, S. Ab.
Published in ANNALS OF ONCOLOGY (2024)

Barriers to accessing essential medicines for kidney disease in low- and lower middle–income countries|

by Francis A.; Abdul Hafidz M.I.; Ekrikpo U.E.; Chen T.; Wijewickrama E.; Tannor E.K.; Nakhoul G.; Wong M.M.Y.; Pereira-Kamath N.; Chanchlani R.; Kalyesubula R.; Karam S.; Kumar V.; Calice-Silva V.; Jha V.
Published in Kidney International (2022)